| Bioactivity | Bamocaftor potassium is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore F508del-CFTR protein function. Bamocaftor potassium can be used combine with Tezacaftor (HY-15448) and Ivacaftor (HY-13017) in cystic fibrosis research[1]. |
| Name | Bamocaftor potassium |
| CAS | 2204245-47-4 |
| Formula | C28H32F3KN5O4S |
| Molar Mass | 630.74 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ghelani DP, et al. Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation. |
Bamocaftor potassium
CAS: 2204245-47-4 F: C28H32F3KN5O4S W: 630.74
Bamocaftor potassium is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore F508d
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.